B
Bryan Burmeister
Researcher at Princess Alexandra Hospital
Publications - 163
Citations - 8693
Bryan Burmeister is an academic researcher from Princess Alexandra Hospital. The author has contributed to research in topics: Radiation therapy & Chemoradiotherapy. The author has an hindex of 39, co-authored 158 publications receiving 7908 citations. Previous affiliations of Bryan Burmeister include Sir Charles Gairdner Hospital & University of Queensland.
Papers
More filters
Journal ArticleDOI
An Ex Vivo Human Tumor Assay Shows Distinct Patterns of EGFR Trafficking in Squamous Cell Carcinoma Correlating to Therapeutic Outcomes.
Shannon R. Joseph,Daniel C Gaffney,Daniel C Gaffney,Rachael Barry,Lingbo Hu,Blerida Banushi,James W. Wells,Duncan Lambie,Geoffrey Strutton,Sandro V. Porceddu,Bryan Burmeister,Graham R. Leggatt,Helmut Schaider,Helmut Schaider,Riccardo Dolcetti,Ian H. Frazer,Nicholas A. Saunders,Matthew Foote,H. Peter Soyer,H. Peter Soyer,Fiona Simpson +20 more
TL;DR: It is shown that EGFR endocytosis is dysregulated in advanced SCC and correlates with anti-EGFR monoclonal antibody therapy outcomes, and these studies in live ex vivo human tumors confirm that endocyTosis dysregulation is a physiological event in human tumors and has therapeutic implications.
Journal ArticleDOI
Outcomes after primary chemoradiotherapy for N3 (>6 cm) head and neck squamous cell carcinoma after an FDG-PET--guided neck management policy.
Gerard Adams,Gerard Adams,Sandro V. Porceddu,Sandro V. Porceddu,David Pryor,David Pryor,Benedict Panizza,Benedict Panizza,Matthew Foote,Matthew Foote,Ann Rowan,Bryan Burmeister,Bryan Burmeister +12 more
TL;DR: The purpose of this study was to assess whether a positron emission tomography (PET)‐directed policy remains appropriate for managing neck nodes in head and neck squamous cell carcinoma (HNSCC).
Journal ArticleDOI
Adjuvant Radiotherapy Improves Regional (Lymph Node Field) Control in Melanoma Patients after Lymphadenectomy: Results of an Intergroup Randomized Trial (TROG 02.01/ANZMTG 01.02)
Bryan Burmeister,Michael A. Henderson,John F. Thompson,Richard I. Fisher,J. Di Iulio,Mark Smithers,Angela Hong,Scott Carruthers,Harald J. Hoekstra,Jill Ainslie +9 more
TL;DR: In this paper, the authors present a survey of the state-of-the-art cancer centers in Australia, including the Peter MacCallum Cancer Centre, Melbourne, Australia, Sydney Melanoma Unit, Sydney, Australia.
Journal ArticleDOI
Promising results of a cooperative group phase II trial of preoperative chemoradiation for locally advanced rectal cancer (TROG 9801).
Samuel Y Ngan,Richard Fisher,Bryan Burmeister,John Mackay,David Goldstein,Andrew Kneebone,David Schache,David Joseph,Joseph McKendrick,Trevor Leong,B. McClure,Danny Rischin +11 more
TL;DR: There is a need for longer follow-up than has commonly been used for the proper evaluation of failures after an effective regimen of preoperative chemoradiation, as this regimen provides excellent local control and favorable overall survival.
Journal ArticleDOI
Results of a phase II, open-label, non-comparative study of intralesional PV-10 followed by radiotherapy for the treatment of in-transit or metastatic melanoma.
Matthew Foote,Matthew Foote,Tavis Read,Tavis Read,Janine Thomas,Michael Wagels,Michael Wagels,Bryan Burmeister,B. Mark Smithers,B. Mark Smithers +9 more
TL;DR: A subset of patients in a phase II trial setting received external beam radiotherapy to their recurrent lesions with complete or partial response and no significant acute radiation reaction.